Susceptibility of Candida species to photodynamic effects of Photofrin

Antimicrobial Agents and Chemotherapy

Volumn 48, Issue 6, 2004, Pages 2000-2006

  Bliss, Joseph M ^a,c   Bigelow, Chad E ^b   Foster, Thomas H ^a,b   Haidaris, Constantine G ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b UNIVERSITY OF ROCHESTER   (United States)

^c RHODE ISLAND HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZIDE; FLUCONAZOLE; PHOTOFRIN;

ARTICLE; CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA KRUSEI; CONFOCAL MICROSCOPY; CULTURE MEDIUM; DOSE RESPONSE; ELECTRON TRANSPORT; FUNGAL METABOLISM; FUNGUS GROWTH; INTERNALIZATION; NONHUMAN; PHOTODYNAMIC THERAPY; PHOTOTOXICITY; PRIORITY JOURNAL;

CANDIDA; CULTURE MEDIA; DIHEMATOPORPHYRIN ETHER; LIGHT; MICROSCOPY, CONFOCAL; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; TETRAZOLIUM SALTS;

EID: 2542483666     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.48.6.2000-2006.2004     Document Type: Article

References (25)

1. Bertoloni, G., E. Reddi, M. Gatta, C. Burlini, and G. Jori. 1989. Factors influencing the hematoporphyrin-sensitized photoinactivation of Candida albicans. J. Gen. Microbiol. 135:957-966.
2. Bigelow, C. E., C. J. Harkrider, D. L. Conover, T. H. Foster, I. Georgakoudi, S. Mitra, M. G. Nichols, and M. Rajadhyaksha. 2001. Retrofitted confocal laser scanner for a commercial inverted fluorescence microscope. Rev. Sci. Instrum. 72:3407-3410.
3. Calderone, R. A. 2002. Candida and candidiasis. ASM Press, Washington D.C.
4. Dougherty, T. J., C. J. Gomer, B. W. Henderson, G. Jori, D. Kessel, M. Korbelik, J. Moan, and Q. Peng. 1998. Photodynamic therapy. J. Natl. Cancer Inst. 90:889-905.
5. Friedberg, J. S., C. Skema, E. D. Baum, J. Burdick, S. A. Vinogradov, D. F. Wilson, A. D. Horan, and I. Nachamkin. 2001. In vitro effects of photodynamic therapy on Aspergillus fumigatus. J. Antimicrob. Chemother. 48:105-107.
6. Hazen, K. C., J. G. Wu, and J. Masuoka. 2001. Comparison of the hydrophobic properties of Candida albicans and Candida dubliniensis. Infect. Immun. 69:779-786.
7. Johnson, E. M., D. W. Warnock, J. Luker, S. R. Porter, and C. Scully. 1995. Emergence of azole drug resistance in Candida species from HIV-infected patients receiving prolonged fluconazole therapy for oral candidosis. J. Antimicrob. Chemother. 35:103-114.
8. Kurtz, M. B., M. W. Cortelyou, and D. R. Kirsch. 1986. Integrative transformation of Candida albicans, using a cloned Candida ADE2 gene. Mol. Cell. Biol. 6:142-149.
9. Manavathu, M., S. Gunasekaran, Q. Porte, E. Manavathu, and M. Gunasekaran. 1996. Changes in glutathione metabolic enzymes during yeast-to-mycelium conversion of Candida albicans. Can. J. Microbiol. 42:76-79.
10. Marr, K. A., C. N. Lyons, K. Ha, T. R. Rustad, and T. C. White. 2001. Inducible azole resistance associated with a heterogeneous phenotype in Candida albicans. Antimicrob. Agents Chemother. 45:52-59.
11. McCaughan, J. S., Jr. 1999. Photodynamic therapy: a review. Drugs Aging 15:49-68.
12. Meshulam, T., S. M. Levitz, L. Christin, and R. D. Diamond. 1995. A simplified new assay for assessment of fungal cell damage with the tetrazolium dye, (2,3)-bis-(2-methoxy-4-nitro-5-sulphenyl)-(2H)-tetrazolium-5-carboxanilide (XTT). J. Infect. Dis. 172:1153-1156.
13. Moran, G. P., D. J. Sullivan, and D. C. Coleman. 2002. Emergence of non-Candida albicans Candida species as pathogens, p. 37-53. In R. A. Calderone (ed.), Candida and candidiasis. ASM Press, Washington, D.C.
14. Morrow, B., H. Ramsey, and D. R. Soll. 1994. Regulation of phase-specific genes in the more general switching system of Candida albicans strain 3153A. J. Med. Vet. Mycol. 32:287-294.
15. Pfaller, M. A., M. Bale, B. Buschelman, M. Lancaster, A. Espinel-Ingroff, J. H. Rex, and M. G. Rinaldi. 1994. Selection of candidate quality control isolates and tentative quality control ranges for in vitro susceptibility testing of yeast isolates by National Committee for Clinical Laboratory Standards proposed standard methods. J. Clin. Microbiol. 32:1650-1653.
16. Pfaller, M. A., M. Bale, B. Buschelman, M. Lancaster, A. Espinel-Ingroff, J. H. Rex, M. G. Rinaldi, C. R. Cooper, and M. R. McGinnis. 1995. Quality control guidelines for National Committee for Clinical Laboratory Standards recommended broth macrodilution testing of amphotericin B, fluconazole, and flucytosine. J. Clin. Microbiol. 33:1104-1107.
17. Rustchenko, E. P., D. H. Howard, and F. Sherman. 1997. Variation in assimilating functions occurs in spontaneous Candida albicans mutants having chromosomal alterations. Microbiology 143:1765-1778.
18. Smijs, T. G., and H. J. Schuitmaker. 2003. Photodynamic inactivation of the dermatophyte Trichophyton rubrum. Photochem. Photobiol. 77:556-560.
19. Teichert, M. C., J. W. Jones, M. N. Usacheva, and M. A. Biel. 2002. Treatment of oral candidiasis with methylene blue-mediated photodynamic therapy in an immunodeficient murine model. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 93:155-160.
20. Vargas, K., P. W. Wertz, D. Drake, B. Morrow, and D. R. Soll. 1994. Differences in adhesion of Candida albicans 3153A cells exhibiting switch phenotypes to buccal epithelium and stratum corneum. Infect. Immun. 62:1328-1335.
21. Vernon, D. I., J. A. Holroyd, S. M. Stribbling, and S. B. Brown. 1995. The quantitative determination of Photofrin and Polyhematoporphyrin in plasma: pitfalls and inaccuracies. J. Photochem. Photobiol. B 27:209-217.
22. Wilson, M., and N. Mia. 1993. Sensitisation of Candida albicans to killing by low-power laser light. J. Oral Pathol. Med. 22:354-357.
23. Zeina, B., J. Greenman, D. Corry, and W. M. Purcell. 2003. Antimicrobial photodynamic therapy: assessment of genotoxic effects on keratinocytes in vitro. Br. J. Dermatol. 148:229-232.
24. Zeina, B., J. Greenman, D. Corry, and W. M. Purcell. 2002. Cytotoxic effects of antimicrobial photodynamic therapy on keratinocytes in vitro. Br. J. Dermatol. 146:568-573.
25. Zeina, B., J. Greenman, W. M. Purcell, and B. Das. 2001. Killing of cutaneous microbial species by photodynamic therapy. Br. J. Dermatol. 144:274-278.